POLYPEPTIDE LABORATORIES A/S: Financial statements 2014
CVR: 19056201
Source: annual report 2014, Danish Business Authority
01/01/2014 – 31/12/2014
POLYPEPTIDE LABORATORIES A/S (CVR 19056201) has filed annual accounts for 2014. In 2014, the company reported a gross profit of DKK 36,563,000 and a net result of DKK 17,074,000 compared with DKK 4,939,000 the year before. That is an increase of 120.2% compared with the year before. Equity in the 2014 report amounted to DKK 74,400,000. The solvency ratio was 73%. The company had 26 employees in the financial year.
- Gross Profit
- DKK 36,563,000
- Profit/Loss
- DKK 17,074,000
- Equity
- DKK 74,400,000
- Total Assets
- DKK 101,906,000
- Employees
- 26
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2014 | - | 36.6 mio. | 17.1 mio. | 74.4 mio. | 26 |
| 2013 | - | 16.6 mio. | 4.9 mio. | 57.3 mio. | 31 |
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2014
As of October 10, 2014, EY Godkendt Revisionspartnerselskab has been appointed auditor of POLYPEPTIDE LABORATORIES A/S.
As of October 10, 2014, JUT NR. 2180 A/S has stepped down as auditor of POLYPEPTIDE LABORATORIES A/S.
POLYPEPTIDE LABORATORIES A/S has published its annual report for 2013. Gross profit came to DKK 16,605,000, and the net result was DKK 4,939,000.
About POLYPEPTIDE LABORATORIES A/S
POLYPEPTIDE LABORATORIES A/S is a Danish company of the type Aktieselskab based in Hillerød, founded in 1996. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named A/S PSE NR. 4948. The management consists of Raoul Bernhardt. The board consists of Juan José Gonzalez Casanova (chair), Christina Ellen Del Vecchio and Raoul Bernhardt. The company is owned by PolyPeptide Laboratories Holding (PPL) AB. The company has 0 employees (2017). In 2025, the company reported a net result of DKK 2,632,000 compared with DKK 7,060,000 the year before. Equity in the 2025 report amounted to DKK 75,499,000.